The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2024
Synopsis
Pneumococcal conjugate 10-valent vaccine – consisting of 1 microgram of polysaccharide for serotypes 1, 5, 6B, 7F, 9V, 14 and 23F, and 3 micrograms of serotypes 4, 18C and 19F.
The global 10-Valent Pneumococcal Polysaccharide Vaccine market was valued at US$ 396 million in 2023 and is anticipated to reach US$ 249.4 million by 2030, witnessing a CAGR of -5.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for 10-Valent Pneumococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 10-Valent Pneumococcal Polysaccharide Vaccine.
Report Scope
The 10-Valent Pneumococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global 10-Valent Pneumococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 10-Valent Pneumococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Segment by Type
Single Dose Vial
Pre-filled Syringe
Segment by Application
Hospital
Clinic
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 10-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of 10-Valent Pneumococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pneumococcal conjugate 10-valent vaccine – consisting of 1 microgram of polysaccharide for serotypes 1, 5, 6B, 7F, 9V, 14 and 23F, and 3 micrograms of serotypes 4, 18C and 19F.
The global 10-Valent Pneumococcal Polysaccharide Vaccine market was valued at US$ 396 million in 2023 and is anticipated to reach US$ 249.4 million by 2030, witnessing a CAGR of -5.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for 10-Valent Pneumococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 10-Valent Pneumococcal Polysaccharide Vaccine.
Report Scope
The 10-Valent Pneumococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global 10-Valent Pneumococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 10-Valent Pneumococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Segment by Type
Single Dose Vial
Pre-filled Syringe
Segment by Application
Hospital
Clinic
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 10-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of 10-Valent Pneumococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 10-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of 10-Valent Pneumococcal Polysaccharide Vaccine
1.2 10-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
1.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 10-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
1.3.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2030
1.4.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2030
1.4.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 10-Valent Pneumococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global 10-Valent Pneumococcal Polysaccharide Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of 10-Valent Pneumococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 10-Valent Pneumococcal Polysaccharide Vaccine, Product Type & Application
2.7 10-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.7.1 10-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest 10-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue
2.7.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 10-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario by Region
3.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2019-2030
3.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2019-2024
3.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2025-2030
3.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2019-2030
3.3.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2019-2024
3.3.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2025-2030
3.4 North America 10-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 North America 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.4.3 North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.5.1 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.5.3 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America 10-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Latin America 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.7.3 Latin America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2030)
4.1.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024)
4.1.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2025-2030)
4.1.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2030)
4.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2030)
4.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2024)
4.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2025-2030)
4.2.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2030)
5.1.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024)
5.1.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2025-2030)
5.1.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2030)
5.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2030)
5.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2024)
5.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2025-2030)
5.2.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 10-Valent Pneumococcal Polysaccharide Vaccine Industry Chain Analysis
7.2 10-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 10-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process
7.4 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Marketing
7.4.1 10-Valent Pneumococcal Polysaccharide Vaccine Sales Channels
7.4.2 10-Valent Pneumococcal Polysaccharide Vaccine Distributors
7.5 10-Valent Pneumococcal Polysaccharide Vaccine Customers
8 10-Valent Pneumococcal Polysaccharide Vaccine Market Dynamics
8.1 10-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
8.2 10-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
8.3 10-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
8.4 10-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
